MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.

The US Food and Drug Administration (FDA) has approved Antares Pharma, Inc's Abbreviated New Drug Application (ANDA) for 4 mg/0.5 ml and 6 mg/0.5 ml Sumatriptan injection USP in adults for the acute ...

Zogenix, Inc. a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, confirmed that a recently issued patent (US patent number ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia Acquisition of Zembrace® SymTouch® ...

Dr Reddy's Laboratories launched the drug in US market which is going to show some amount of incremental momentum for the US market. They have launched Sumatriptan Injection USP, which is an ...